BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moldogazieva NT, Mokhosoev IM, Terentiev AA. Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK. Cancers (Basel) 2020;12:E862. [PMID: 32252351 DOI: 10.3390/cancers12040862] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Schiliro C, Firestein BL. Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation. Cells 2021;10:1056. [PMID: 33946927 DOI: 10.3390/cells10051056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
2 Ortega-lozano AJ, Gómez-caudillo L, Briones-herrera A, Aparicio-trejo OE, Pedraza-chaverri J. Characterization of Mitochondrial Proteome and Function in Luminal A and Basal-like Breast Cancer Subtypes Reveals Alteration in Mitochondrial Dynamics and Bioenergetics Relevant to Their Diagnosis. Biomolecules 2022;12:379. [DOI: 10.3390/biom12030379] [Reference Citation Analysis]
3 Du W, Gu C, Guo P, Zhou Y, Tan W. The adverse effects of hypoxia on hiHep functions via HIF-1α/PGC-1α axis are alleviated by PFDC emulsion. Biochemical Engineering Journal 2021;176:108152. [DOI: 10.1016/j.bej.2021.108152] [Reference Citation Analysis]
4 Sung JY, Cheong JH. Pan-Cancer Analysis Reveals Distinct Metabolic Reprogramming in Different Epithelial-Mesenchymal Transition Activity States. Cancers (Basel) 2021;13:1778. [PMID: 33917859 DOI: 10.3390/cancers13081778] [Reference Citation Analysis]
5 Soni VK, Mehta A, Ratre YK, Chandra V, Shukla D, Kumar A, Vishvakarma NK. Counteracting Action of Curcumin on High Glucose-Induced Chemoresistance in Hepatic Carcinoma Cells. Front Oncol 2021;11:738961. [PMID: 34692517 DOI: 10.3389/fonc.2021.738961] [Reference Citation Analysis]
6 Liu X, Zhang Q, Zhao Y, Xun J, Wu H, Feng H. Association of JMJD2B and Hypoxia-Inducible Factor 1 Expressions with Poor Prognosis in Osteosarcoma. Anal Cell Pathol (Amst) 2020;2020:2563208. [PMID: 32802732 DOI: 10.1155/2020/2563208] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Reyes A, Duarte LF, Farías MA, Tognarelli E, Kalergis AM, Bueno SM, González PA. Impact of Hypoxia over Human Viral Infections and Key Cellular Processes. Int J Mol Sci 2021;22:7954. [PMID: 34360716 DOI: 10.3390/ijms22157954] [Reference Citation Analysis]
8 Tu H, Ma D, Luo Y, Tang S, Li Y, Chen G, Wang L, Hou Z, Shen C, Lu H, Zhuang X, Zhang L. Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway. Bioengineered 2021;12:6538-58. [PMID: 34528858 DOI: 10.1080/21655979.2021.1973877] [Reference Citation Analysis]
9 Reiter RJ, Sharma R, Rosales-Corral S. Anti-Warburg Effect of Melatonin: A Proposed Mechanism to Explain its Inhibition of Multiple Diseases. Int J Mol Sci 2021;22:E764. [PMID: 33466614 DOI: 10.3390/ijms22020764] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
10 Kabakov AE, Yakimova AO. Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing. Cancers (Basel) 2021;13:1102. [PMID: 33806538 DOI: 10.3390/cancers13051102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
11 Zhang C, Li L, Zhang Y, Zeng C. Hereditary Leiomyomatosis and Renal Cell Cancer: Recent Insights Into Mechanisms and Systemic Treatment. Front Oncol 2021;11:686556. [PMID: 34113573 DOI: 10.3389/fonc.2021.686556] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Wang S, Cai Y, Feng Q, Gao J, Teng B. Pseudoginsengenin DQ exerts antitumour activity against hypopharyngeal cancer cells by targeting the HIF-1α-GLUT1 pathway. Cancer Cell Int 2021;21:382. [PMID: 34281558 DOI: 10.1186/s12935-021-02080-x] [Reference Citation Analysis]
13 Hua H, Zhang H, Chen J, Wang J, Liu J, Jiang Y. Targeting Akt in cancer for precision therapy. J Hematol Oncol 2021;14:128. [PMID: 34419139 DOI: 10.1186/s13045-021-01137-8] [Reference Citation Analysis]
14 Kou L, Jiang X, Tang Y, Xia X, Li Y, Cai A, Zheng H, Zhang H, Ganapathy V, Yao Q, Chen R. Resetting amino acid metabolism of cancer cells by ATB0,+-targeted nanoparticles for enhanced anticancer therapy. Bioact Mater 2022;9:15-28. [PMID: 34820552 DOI: 10.1016/j.bioactmat.2021.07.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Akman M, Belisario DC, Salaroglio IC, Kopecka J, Donadelli M, De Smaele E, Riganti C. Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons. J Exp Clin Cancer Res 2021;40:28. [PMID: 33423689 DOI: 10.1186/s13046-020-01824-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Wang S, Lv Y, Zhou Y, Ling J, Wang H, Gu D, Wang C, Qin W, Zheng X, Jin H. Acidic extracellular pH induces autophagy to promote anoikis resistance of hepatocellular carcinoma cells via downregulation of miR-3663-3p. J Cancer 2021;12:3418-26. [PMID: 33995620 DOI: 10.7150/jca.51849] [Reference Citation Analysis]
17 Eckert AW, Kappler M, Große I, Wickenhauser C, Seliger B. Current Understanding of the HIF-1-Dependent Metabolism in Oral Squamous Cell Carcinoma. Int J Mol Sci 2020;21:E6083. [PMID: 32846951 DOI: 10.3390/ijms21176083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Ma P, Chen J, Qu H, Li Y, Li X, Tang X, Song Z, Xin H, Zhang J, Nai J, Li Z, Wang Z. Hypoxic targeting and activating TH-302 loaded transcatheter arterial embolization microsphere. Drug Deliv 2020;27:1412-24. [PMID: 33096947 DOI: 10.1080/10717544.2020.1831102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Averbeck D, Rodriguez-Lafrasse C. Role of Mitochondria in Radiation Responses: Epigenetic, Metabolic, and Signaling Impacts. Int J Mol Sci 2021;22:11047. [PMID: 34681703 DOI: 10.3390/ijms222011047] [Reference Citation Analysis]
20 Belisario DC, Kopecka J, Pasino M, Akman M, De Smaele E, Donadelli M, Riganti C. Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance. Cells 2020;9:E2598. [PMID: 33291643 DOI: 10.3390/cells9122598] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
21 Cioce M, Pulito C, Strano S, Blandino G, Fazio VM. Metformin: Metabolic Rewiring Faces Tumor Heterogeneity. Cells 2020;9:E2439. [PMID: 33182253 DOI: 10.3390/cells9112439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
22 Rampias T. Oropharyngeal cancer: the dawn of the RNA era in precision medicine. EBioMedicine 2020;61:102857. [PMID: 33096479 DOI: 10.1016/j.ebiom.2020.102857] [Reference Citation Analysis]
23 Giani M, Montoyo-Pujol YG, Peiró G, Martínez-Espinosa RM. Halophilic Carotenoids and Breast Cancer: From Salt Marshes to Biomedicine. Mar Drugs 2021;19:594. [PMID: 34822465 DOI: 10.3390/md19110594] [Reference Citation Analysis]
24 Askar MA, Thabet NM, El-Sayyad GS, El-Batal AI, Abd Elkodous M, El Shawi OE, Helal H, Abdel-Rafei MK. Dual Hyaluronic Acid and Folic Acid Targeting pH-Sensitive Multifunctional 2DG@DCA@MgO-Nano-Core-Shell-Radiosensitizer for Breast Cancer Therapy. Cancers (Basel) 2021;13:5571. [PMID: 34771733 DOI: 10.3390/cancers13215571] [Reference Citation Analysis]
25 Ashrafizadeh M, Mirzaei S, Hushmandi K, Rahmanian V, Zabolian A, Raei M, Farahani MV, Goharrizi MASB, Khan H, Zarrabi A, Samarghandian S. Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects. Life Sci 2021;278:119649. [PMID: 34043989 DOI: 10.1016/j.lfs.2021.119649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Han Y, Chen Q, Zhang L, Dissanayaka WL. Indispensable Role of HIF-1α Signaling in Post-implantation Survival and Angio-/Vasculogenic Properties of SHED. Front Cell Dev Biol 2021;9:655073. [PMID: 34368116 DOI: 10.3389/fcell.2021.655073] [Reference Citation Analysis]
27 Suwannakul N, Armartmuntree N, Thanan R, Midorikawa K, Kon T, Oikawa S, Kobayashi H, Ma N, Kawanishi S, Murata M. Targeting fructose metabolism by glucose transporter 5 regulation in human cholangiocarcinoma. Genes & Diseases 2021. [DOI: 10.1016/j.gendis.2021.09.002] [Reference Citation Analysis]
28 Shin E, Koo JS. Glucose Metabolism and Glucose Transporters in Breast Cancer. Front Cell Dev Biol 2021;9:728759. [PMID: 34552932 DOI: 10.3389/fcell.2021.728759] [Reference Citation Analysis]
29 Varghese E, Samuel SM, Líšková A, Samec M, Kubatka P, Büsselberg D. Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer. Cancers (Basel) 2020;12:E2252. [PMID: 32806533 DOI: 10.3390/cancers12082252] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
30 Ancel J, Perotin JM, Dewolf M, Launois C, Mulette P, Nawrocki-Raby B, Dalstein V, Gilles C, Deslée G, Polette M, Dormoy V. Hypoxia in Lung Cancer Management: A Translational Approach. Cancers (Basel) 2021;13:3421. [PMID: 34298636 DOI: 10.3390/cancers13143421] [Reference Citation Analysis]
31 Bao X, Zhang J, Huang G, Yan J, Xu C, Dou Z, Sun C, Zhang H. The crosstalk between HIFs and mitochondrial dysfunctions in cancer development. Cell Death Dis 2021;12:215. [PMID: 33637686 DOI: 10.1038/s41419-021-03505-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Nakano H, Fajardo VM, Nakano A. The role of glucose in physiological and pathological heart formation. Dev Biol 2021;475:222-33. [PMID: 33577830 DOI: 10.1016/j.ydbio.2021.01.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Sebestyén A, Kopper L, Dankó T, Tímár J. Hypoxia Signaling in Cancer: From Basics to Clinical Practice. Pathol Oncol Res 2021;27:1609802. [PMID: 34257622 DOI: 10.3389/pore.2021.1609802] [Reference Citation Analysis]
34 Feng J, Li J, Wu L, Yu Q, Ji J, Wu J, Dai W, Guo C. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res 2020;39:126. [PMID: 32631382 DOI: 10.1186/s13046-020-01629-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 11.5] [Reference Citation Analysis]
35 Li TT, Zhu HB. LKB1 and cancer: The dual role of metabolic regulation. Biomed Pharmacother 2020;132:110872. [PMID: 33068936 DOI: 10.1016/j.biopha.2020.110872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Urra FA, Fuentes-Retamal S, Palominos C, Rodríguez-Lucart YA, López-Torres C, Araya-Maturana R. Extracellular Matrix Signals as Drivers of Mitochondrial Bioenergetics and Metabolic Plasticity of Cancer Cells During Metastasis. Front Cell Dev Biol 2021;9:751301. [PMID: 34733852 DOI: 10.3389/fcell.2021.751301] [Reference Citation Analysis]
37 Li Y, Sun XX, Qian DZ, Dai MS. Molecular Crosstalk Between MYC and HIF in Cancer. Front Cell Dev Biol 2020;8:590576. [PMID: 33251216 DOI: 10.3389/fcell.2020.590576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
38 Zhang Q, Han Z, Zhu Y, Chen J, Li W. Role of hypoxia inducible factor-1 in cancer stem cells (Review). Mol Med Rep 2021;23:17. [PMID: 33179080 DOI: 10.3892/mmr.2020.11655] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
39 Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond) 2021;41:109-20. [PMID: 33119215 DOI: 10.1002/cac2.12108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
40 Chen Y, Liu L, Xia L, Wu N, Wang Y, Li H, Chen X, Zhang X, Liu Z, Zhu M, Liao Q, Wang J. TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation. J Exp Clin Cancer Res 2022;41. [DOI: 10.1186/s13046-022-02252-1] [Reference Citation Analysis]